Building on our team’s broad global experiences and capabilities to develop and commercialize therapies, Immunicom is accelerating the path to make immunotherapies accessible to broad-based patient populations via partnerships with leading hospitals around the world.

Leveraging a proprietary technology platform, we are on a mission to dramatically shorten the time to develop important immunotherapies, sometimes by as much as two-thirds, significantly reducing the time required to bring safe and effective immunotherapies to market.

Collectively, our leadership team and its board members have commercialized more than 50 pharmaceuticals and therapeutic devices, generating billions of dollars in value and bringing meaningful therapies to innumerable patients who need them.

Whether it is securing funding or regulatory approval or overseeing clinical trials and device development, our accomplished team produces results.

Immunicom is developing a revolutionary new treatment that addresses issues still plaguing the healthcare industry: side effects, quality of life, and cost.

Amir Jafri,
CEO & Founder

Our team

Amir Jafri, CEO of Immunicom

Amir Jafri

CEO, Founder

Photo of Raju Chauhan

Raju Chauhan

Chief Operating Officer

Photo of lDave L. Lopez

Dave L. Lopez, Esq., CPA

General Counsel

Photo of Steve Prince

Steve Prince

Chief Commercial Officer

Photo of Lawrence Florin

Lawrence Florin

Chief Clinical Officer

Christian Shenouda, M.D.

Vice President of Regulatory Affairs

Photo of Marilyn Panahi

Marilyn Panahi

Vice President of Quality

Photo of Steven Josephs

Steven Josephs, Ph.D.

Chief Scientist

Jennifer Haldeman

Vice President of Commercial Operations

Photo of Johan Louw

Johan Louw

Vice President of Strategic Programs

Photo of Adam Ostrowski

Adam Ostrowski, M.D.

Medical Director, International

Kamel Djazouli, M.D.

Vice President Global Medical Affairs

Board of directors

Michael Perry – Chairman of Board

Amir Jafri

Gary Pace, Ph.D.

D. John Miller

Michael Barrett

Peter C. Farrell, PhD, DSc, AM

Michael E. Lehman

John Rompon – Board Observer

Wayne Jonas, M.D. – Board Observer

Get in touch today

Let’s talk about what we can achieve together

Learn more about
our team